相关实验视频
Updated: Jan 14, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
902
印度尼西亚的内科医生中肥胖和心血管风险因素
Sally Aman Nasution1, Lugyanti Sukrisman1, Eka Ginanjar1
1Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Special Capital Region of Jakarta, Indonesia.
Frontiers in endocrinology
|October 17, 2025
概括
肥胖影响超过60%的印度尼西亚内科医生,比一般人口更高的患病率. 关键的危险因素包括男性性别,高血压,糖尿病史和身体活动不足.
科学领域:
- 公共卫生 公共卫生
- 内部医学 内部医学
- 流行病学 流行病学
背景情况:
- 肥胖是一个全球性的健康问题,对非传染性疾病有重大影响.
- 包括内科医生在内的医生容易患肥胖,这会影响他们的健康和表现.
- 内科医生在管理肥胖方面发挥着至关重要的作用,使自己的健康状况成为研究的关键领域.
研究的目的:
- 为了确定印度尼西亚内科医生中肥胖的患病率.
- 为了确定与肥胖相关的可修改和不可修改的风险因素,在这个专业群体.
主要方法:
- 一项多中心随机横截面研究,涉及印度尼西亚1064名内科医生.
- 通过问卷,体检和生物化学测试收集数据.
- 统计分析包括描述性,双变量和多变量方法.
主要成果:
- 发现印尼内科医生中肥胖的患病率为61.4%.
- 确定的重大风险因素包括男性性别,高血压,糖尿病史,新诊断的糖尿病,新诊断的糖尿病前期,以及身体活动不足.
结论:
- 与一般人口相比,印度尼西亚的内科医生患肥胖率更高.
- 高职业要求可能会影响生活方式的选择,导致内科医生肥胖.
- 了解这些特定的风险因素对于针对内科医生进行有针对性的健康干预至关重要.
相关概念视频
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
245
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
245
Drug Dosing: Obese Patients
218
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
218
Coronary Artery Disease I: Introduction
876
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
876
Coronary Artery Disease IV: Preventive Measures
584
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
584
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319

